Published Technical Disclosure Archive

Specialized Iron Supplementation Solutions for Niche Environments

Publication ID: 24-11857583_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Iron Supplementation Solutions for Niche Environments,” Published Technical Disclosure No. 24-11857583_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857583_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,583.

Summary of the Inventive Concept

This inventive concept adapts Lactiplantibacillus plantarum TCI837-based iron supplements for unique operational environments, enhancing iron absorption and addressing specific health needs in high-altitude, space, disaster relief, and high-security settings.

Background and Problem Solved

The original patent disclosed Lactiplantibacillus plantarum TCI837 for general iron supplementation. However, this invention addresses the limitations of the original patent by providing tailored solutions for specific, high-demand environments where standard iron supplements may be ineffective or unstable.

Detailed Description of the Inventive Concept

The inventive concept comprises a range of specialized iron supplementation systems, each designed to overcome the challenges of a particular niche environment. For example, the high-altitude system utilizes a Lactiplantibacillus plantarum TCI837-based composition that enhances iron absorption at low oxygen levels. The space-based system incorporates a radiation-resistant Lactiplantibacillus plantarum TCI837-containing composition to promote gut health in astronauts. The disaster relief composition remains stable at high temperatures and humidity, while the high-security system enables covert administration and maintains effectiveness under extreme stress conditions.

Novelty and Inventive Step

The new claims introduce novel, non-obvious adaptations of Lactiplantibacillus plantarum TCI837-based iron supplements for specific, high-demand environments. These adaptations provide a significant improvement over the original patent by addressing the unique challenges of each environment.

Alternative Embodiments and Variations

Alternative embodiments may include customized formulations for other niche environments, such as extreme weather conditions or specialized medical settings. Variations could also involve the use of different strains of Lactiplantibacillus plantarum or combination therapies with other nutrients or supplements.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in various industries, including aerospace, disaster relief, high-security operations, and specialized healthcare. The market demand for tailored iron supplementation solutions is substantial, particularly in environments where standard supplements are ineffective or unreliable.

CPC Classifications

SectionClassGroup
A A61 A61K35/747
A A61 A61K33/26
C C12 C12N1/205

Field of Art

Microbiology and nutritional supplements, specifically probiotic bacterial strains for iron supplementation and absorption, with expertise in microbiological strain manipulation, nutritional formulation, and biotechnological applications

Person of Ordinary Skill (PHOSITA) Profile

A researcher or practitioner with advanced microbiology training, understanding of probiotic strain characteristics, experience in nutritional supplement development, and knowledge of bacterial strain adaptation techniques

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's Lactiplantibacillus plantarum TCI837 provides a foundational probiotic strain that can be readily adapted to specific environmental conditions by applying standard microbiological and formulation techniques. The PTD's variations represent predictable extensions of the original bacterial strain's iron supplementation capabilities, utilizing known methods of strain characterization and environmental adaptation. These modifications would be considered routine optimization within the field of probiotic supplement development.

Obvious Combinations & Variations

Source Patent Element
Lactiplantibacillus plantarum TCI837 for iron absorption
PTD Variation
High-altitude adaptation of bacterial strain to enhance iron absorption at low oxygen levels
Obviousness Reasoning
Predictable modification using known techniques of bacterial strain environmental adaptation, where a PHOSITA would understand how to modify bacterial metabolic processes for specific oxygen conditions
Source Patent Element
Iron supplementation method using bacterial strain
PTD Variation
Space-based radiation-resistant formulation for astronaut gut health
Obviousness Reasoning
Routine application of known radiation resistance techniques to probiotic strains, representing a standard approach to developing specialized microbial supplements
Source Patent Element
Composition for iron absorption and supplementation
PTD Variation
Disaster relief formulation stable at high temperatures and humidity
Obviousness Reasoning
Predictable result of standard pharmaceutical formulation techniques, where a PHOSITA would apply known stabilization methods to maintain bacterial viability
Source Patent Element
Method of administering Lactiplantibacillus plantarum TCI837
PTD Variation
Covert administration system for high-security environments
Obviousness Reasoning
Obvious design variation using known pharmaceutical delivery techniques, representing a straightforward adaptation of existing supplement administration methods
Source Patent Element
Iron absorption enhancement method
PTD Variation
Hemochromatosis-specific supplement to reduce iron absorption
Obviousness Reasoning
Predictable medical application of known bacterial strain characteristics, representing a standard approach to developing targeted nutritional interventions
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the Published Technical Disclosure (PTD) would have been obvious to a person having ordinary skill in the art at the time of invention, based on the teachings of US Patent 11857583. The PTD demonstrates that the Lactiplantibacillus plantarum TCI837 strain can be readily adapted to various environmental and medical contexts through routine microbiological and formulation techniques, thereby rendering subsequent claims of novelty non-patentable.

Original Patent Information

Patent NumberUS 11,857,583
TitleLactiplantibacillus plantarum TCI837, methods for using the same, and iron supplement composition having the same
Assignee(s)TCI CO., LTD.